Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up.

ABSTRACT:

Trial registration

ClinicalTrials.gov number: NCT01777152.

SUBMITTER: Domingo-Domenech E 

PROVIDER: S-EPMC12317119 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature